Trib Total Media
newspapers web sites magazines your town classifieds partners advertise help
 
 Cel Sci Corp - CVM (AMEX)   1.30    +0.01  +0.78%   PRINT THIS
  EMAIL THIS
Overview News Releases Company Profile
Quote
Last Traded: 11/20/09 16:02 ET
Last 1.30
Change   +0.01
% Change +0.78%
Open 1.28
Bid 1.32
Bid Size 2,500
Ask 1.32
Ask Size 1,000
Day High 1.35
Day Low 1.25
52 Week High 2.10
52 Week Low 0.1402
Volume 3,223,676
Prev. Close 1.29
Tick Type EVEN
Last Trade Shr. 23,900
Industry: HEALTHCARE - DRUGS
 
Add CVM To :
  >> My Portfolio
  >> My Watchlist
  >> My StockAlerts
  >> message
  
Date Range:  Intraday | 5_Days | 15_Days | 1_Month | 3_Months | 1_Year | 2_Years | 3_Years
News Releases
CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
11/18/2009 9:45 AM - PR Newswire
TheFortuneFinancial.com Progressive Review on F, HMA, JBL, FRE, TD and CVM
11/17/2009 6:55 AM - Marketwire
Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big?
11/12/2009 7:30 AM - Business Wire
CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
11/9/2009 9:40 AM - PR Newswire
D.C. Vaccine Conference Attracts Government Policy Makers and Biotech Innovators
11/9/2009 8:26 AM - Business Wire

>> More CVM News Releases
Company Profile

The Company is engaged in the research and development of drugs and vaccines for the treatment of cancer.

>> More CVM Profile Information


CEL-SCI CORP
8229 Boone Boulevard
Suite 802
Vienna, VA US
22182

Website: http://www.cel-sci.com
Email: gdewindt@cel-sci.com

Officers: Geert R. Kersten, CEO


Fundamental Data
P/E Ratio
Earnings/Share-0.1
Dividend/Share0
Cur Div Yield0.0
Ex Div Date
Market Cap (Mil)194.42
Share Out (mil)149.55
 
Recommendations
No Recommendations.
Financial Highlights (All data for latest 12 months) Values in
Sales 0.05 Mil   Revenue/Share 0.00
Income -11.09 Mil   Earnings/Share -0.10
Net Profit Margin -   Book Value/Share 0.07
Return on Equity -   Dividend Rate 0.00
Debt/Equity Ratio 0.10   Payout Ratio< 0.00%
 
Revenue - Quarterly Results (in millions)
  6/2009 6/2008 6/2007
 1st Qtr 0.0 0.0 0.0
 2nd Qtr 0.0 0.0 0.0
 3rd Qtr 0.0 0.0 0.0
 4th Qtr 0.0 0.0 0.0
 Total 0.1 0.0 0.1
 
Earnings Per Share - Quarterly Results
  6/2009 6/2008 6/2007
 1st Qtr ($0.01) $0.00 ($0.06)
 2nd Qtr ($0.02) ($0.02) ($0.01)
 3rd Qtr ($0.02) ($0.03) ($0.03)
 4th Qtr ($0.05) ($0.02) ($0.05)
 Total ($0.10) ($0.07) ($0.15)
My Last 5 Quotes
CL/09Z $76.72 -$0.74
BAC $16.09 $0.01
GOOG $569.964 -$3.026
WFC $27.87 -$0.45
AAPL $199.92 -$0.59
Market Indexes
DOW 10318.16 EVEN
NASD 2146.04 EVEN
NYSE 7084.47 EVEN
S&P 500 1091.38 EVEN
TSX 11579.33 EVEN
TSX-V 1408.06 EVEN
Russell 584.68 EVEN
AMEX 1782.07 EVEN



 Watchlist Edit
No watchlist stocks
 

Quotes delayed at least 20 minutes for NYSE/AMEX, 15 minutes for other exchanges.
© 2009 Stockgroup. Terms & Conditions. Privacy Policy.  Corporate and Financial data provided by Morningstar.


Subscribe to the Tribune-Review today



Advertising Information | Advertiser List